Login / Signup

Oncolytic adenovirus H101 ameliorate the efficacy of anti-PD-1 monotherapy in colorectal cancer.

Lili HuangHuaxin ZhaoMengying ShanHong ChenBin XuYang HeYu ZhaoZhuqing LiuJianhua ChenQing Xu
Published in: Cancer medicine (2022)
promotes intratumor T cell infiltration and improves anti-PD-1 immunotherapy, thereby providing a potent combinatorial therapeutic strategy for CRC.
Keyphrases
  • combination therapy
  • open label
  • anti inflammatory
  • randomized controlled trial
  • study protocol